Percentages of absence of SCR at follow-up
| . | No SCR at end of follow-up, n/total (%) . | P value∗ . |
|---|---|---|
| HbSS/HbSβ0/HbSβ+ | 51 of 83 (61.4) | .025 |
| Male | 19 of 39 (48.7) | |
| Female | 32 of 44 (72.7) | |
| HbSC | 14 of 46 (30.4) | .177 |
| Male | 4 of 20 (20) | |
| Female | 10 of 26 (38.5) |
| . | No SCR at end of follow-up, n/total (%) . | P value∗ . |
|---|---|---|
| HbSS/HbSβ0/HbSβ+ | 51 of 83 (61.4) | .025 |
| Male | 19 of 39 (48.7) | |
| Female | 32 of 44 (72.7) | |
| HbSC | 14 of 46 (30.4) | .177 |
| Male | 4 of 20 (20) | |
| Female | 10 of 26 (38.5) |
Pearson χ2.